Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -11.15%707.1B | 12.39%795.8B | -3.98%185.64B | 9.84%206.83B | 14.86%198.67B | 33.35%204.67B | 23.76%708.07B | 17.90%193.33B | 30.29%188.29B | 36.52%172.97B |
| Cost of revenue | -11.62%661.32B | 10.84%748.26B | -3.99%174.69B | 8.05%193.27B | 13.54%187.12B | 29.28%193.18B | 24.32%675.06B | 18.07%181.95B | 29.82%178.88B | 34.04%164.81B |
| Gross profit | -3.69%45.79B | 44.01%47.54B | -3.74%10.95B | 44.01%13.56B | 41.47%11.54B | 182.87%11.49B | 13.42%33.01B | 15.33%11.38B | 39.96%9.41B | 117.72%8.16B |
| Operating expense | 8.06%30.61B | 11.83%28.33B | 25.60%7.75B | 5.14%6.99B | 6.01%6.83B | 11.35%6.76B | 10.17%25.33B | 3.04%6.17B | 14.93%6.65B | 13.86%6.44B |
| Operating profit | -21.00%15.18B | 150.14%19.21B | -38.50%3.2B | 137.57%6.56B | 174.35%4.72B | 335.44%4.73B | 25.61%7.68B | 34.30%5.21B | 194.25%2.76B | 190.05%1.72B |
| Net non-operating interest income (expenses) | 27.20%-273M | 68.57%-375M | 116.27%54M | 76.66%-88M | 51.74%-125M | 4.00%-216M | -61.43%-1.19B | -66.83%-332M | -92.35%-377M | -57.93%-259M |
| Non-operating interest income | -14.10%530M | 195.22%617M | 100.93%215M | 270.00%148M | 240.91%150M | 477.78%104M | 129.67%209M | 224.24%107M | 66.67%40M | 193.33%44M |
| Non-operating interest expense | -19.05%803M | -29.24%992M | -63.33%161M | -43.41%236M | -9.24%275M | 31.69%320M | 68.92%1.4B | 89.22%439M | 89.55%417M | 69.27%303M |
| Net investment income | -215.04%-1.29B | 325.76%1.12B | 283.87%1.07B | -1,233.85%-737M | 228.69%314M | 190.24%476M | -74.81%264M | -34.20%279M | -74.41%65M | -542.11%-244M |
| Gain(Loss) on financial instruments designated as cash flow hedges | 208.12%719M | -1,562.50%-665M | -1,127.50%-491M | 206M | -40M | -40M | 0 | |||
| Gain(Loss) on derecognition of available-for-sale financial assets | 1.58B | 0 | 1,643.48%1.6B | |||||||
| Income from associates and other participating interests | 219.33%179M | -157.69%-150M | -227.27%-28M | -78.26%15M | -3,975.00%-155M | -89.09%18M | -63.33%260M | -81.20%22M | -78.30%69M | -98.11%4M |
| Special income (charges) | -14,111.43%-4.97B | 97.15%-35M | 101.81%25M | -715.38%-80M | -12.66%69M | -176.56%-49M | 29.97%-1.23B | -153.66%-1.39B | -76.79%13M | 147.59%79M |
| Less:Restructuring and mergern&acquisition | --2.62B | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | 422.86%183M | 115.56%35M | 63.77%-25M | 715.38%80M | 12.66%-69M | 176.56%49M | -118.40%-225M | -592.86%-69M | 76.79%-13M | -147.59%-79M |
| Less:Write off | --2.17B | --0 | ---- | ---- | ---- | ---- | 173.31%1.45B | ---- | ---- | ---- |
| Other non-operating income (expenses) | -66.35%-1.04B | -209.28%-624M | -846.09%-955M | 77.68%199M | 93.16%226M | -143.93%-94M | -27.26%571M | -68.70%128M | -30.43%112M | -16.43%117M |
| Income before tax | -45.49%10.08B | 133.54%18.49B | -47.47%2.88B | 130.20%6.08B | 229.00%4.66B | 399.38%4.87B | 26.57%7.92B | 34.29%5.48B | 72.34%2.64B | 177.56%1.42B |
| Income tax | -14.98%4.31B | 269.64%5.07B | 116.81%737M | 175.15%1.81B | 46.01%914M | 1,300.87%1.61B | -246.64%-2.99B | -3,472.31%-4.38B | 35.82%656M | -31.13%626M |
| Net income | -57.00%5.77B | 23.09%13.42B | -78.27%2.14B | 115.42%4.28B | 373.83%3.75B | 287.01%3.25B | 158.51%10.9B | 149.63%9.87B | 89.05%1.99B | 128.91%791M |
| Net income continuous operations | -57.00%5.77B | 23.09%13.42B | -78.28%2.14B | 115.36%4.28B | 373.83%3.75B | 287.01%3.25B | 158.51%10.9B | 149.61%9.87B | 89.14%1.99B | 128.91%791M |
| Noncontrolling interests | -173.90%-436M | 79.88%590M | 285.71%78M | 14.22%249M | -42.07%84M | 2,457.14%179M | -63.96%328M | -125.93%-42M | 25.29%218M | -27.50%145M |
| Net income attributable to the company | -51.62%6.21B | 21.32%12.83B | -79.15%2.07B | 127.84%4.03B | 468.22%3.67B | 275.96%3.07B | 219.81%10.58B | 161.50%9.91B | 101.71%1.77B | 121.98%645M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -51.62%6.21B | 21.32%12.83B | -79.15%2.07B | 127.84%4.03B | 468.22%3.67B | 275.96%3.07B | 219.81%10.58B | 161.50%9.91B | 101.71%1.77B | 121.98%645M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -51.63%69.38 | 21.29%143.44 | -79.16%23.09 | 127.67%45.01 | 468.10%40.96 | 275.95%34.38 | 220.14%118.26 | 161.74%110.82 | 101.94%19.77 | 121.98%7.21 |
| Diluted earnings per share | -51.63%69.38 | 21.29%143.44 | -79.16%23.09 | 127.62%45.0001 | 468.10%40.96 | 275.95%34.38 | 220.14%118.26 | 161.88%110.82 | 102.14%19.77 | 121.98%7.21 |
| Dividend per share | 0.00%35 | 133.33%35 | 33.33%20 | 0 | 15 | 0 | 50.00%15 | 50.00%15 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |